CPT® Code 83037

The CPT® Code 83037 refers to a specific laboratory test known as the glycosylated hemoglobin (HbA1C) test, which is performed using a device that has been cleared by the FDA for home use. This blood test is crucial for measuring the levels of glycosylated hemoglobin, which reflects the average plasma glucose concentration over the lifespan of red blood cells, typically ranging from 90 to 120 days. The HbA1C test is particularly significant for individuals with diabetes mellitus (DM), as it provides valuable insights into their blood glucose control. Elevated HbA1C levels can indicate poor blood sugar management, and therefore, monitoring these levels is essential for effective diabetes management. It is recommended that patients with DM have their HbA1C levels checked at least every six months, with more frequent testing advised when levels exceed 7.0%. The test can be performed using a capillary or venous blood sample, and the process involves placing a drop of blood into a buffer solution to lyse the red blood cells, followed by measuring the HbA1C levels with the home-use testing device. This method allows for convenient and timely monitoring of blood glucose levels, empowering patients to manage their diabetes more effectively.